GlassScriptPhysician profile
Mark William Manoso
NPI 1497728596
$6,139.72
in general payments reported to CMS, 2019-2025
13 companies · $371 in 2025
The $371 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $846 · 2021: $18.36 · 2022: $1,540 · 2023: $2,005 · 2024: $962 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,267 · Food and Beverage: $1,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,267.27 |
| Food and Beverage | $1,070.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $4,331.91 | 2019-2025 | Excelsius3d Imaging System, Excelsiusgps Robotic Navigation System, Excelsius Deformity |
| Zimmer Biomet Holdings, INC. | $816.70 | 2019-2020 | |
| Medtronic USA, INC. | $264.99 | 2019 | |
| Medtronic, INC. | $259.38 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Si-Bone, INC. | $137.72 | 2025 | |
| Intrinsic Therapeutics | $102.88 | 2022-2023 | Barricaid Acd (Annular Closure Device) |
| Providence Medical Technology, INC. | $93.00 | 2024 | |
| Zimvie INC. | $38.70 | 2022 | |
| Djo, LLC | $25.99 | 2020 | |
| Surgalign Spine Technologies, INC. | $21.21 | 2019 | |
| Cerapedics INC. | $17.50 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Left Coast Surgical INC | $15.34 | 2025 | |
| Augmedics INC. | $14.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Manoso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.